The global outbound medical tourism services market size is calculated at USD 247.38 billion in 2024, grew to USD 276.60 billion in 2025 and is projected to reach around USD 755.39 billion by 2034. The market is expanding at a CAGR of 11.81% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Outbound Medical Tourism Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Outbound Medical Tourism Services Market, by Treatment Type, 2024-2034
8.1.1. Dental Treatment
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Cosmetic Treatment
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cardiovascular Treatment
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Orthopedic Treatment
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Neurological Treatment
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Cancer Treatment
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Fertility Treatment
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Treatment Type (2021-2034)
10.1. Apollo Hospitals
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Bumrungrand International Hospitals
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Christus Muguerza S.A.P.I De CV
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Prince Court Medical Center
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Clemenceau Medical Center
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Asian Heart Institute
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Gleneagles Hospital
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. KPJ Healthcare
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Asklepios Kliniken GmbH
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Bangkok Dusit Medical Services
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample